View : 20 Download: 0

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis

Title
Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis
Authors
Kim, Jin SeokSuh, CheolwonCheong, June-WonKim, KihyunKim, Yang SooLee, Se-RyeonBae, Sung HwaJoo, Young-DonLee, Sang MinEom, Hyeon SeokPark, EunkyungYoon, Sung-SooKim, InhoKwak, Jae-YongMin, Chang-KiKim, Jeong-APark, Moo-RimKim, Sung HyunKang, Hye JinKim, Min KyoungKim, HawkMun, Yeung-ChulKim, Hoon-GuLee, Moon HeeLee, Jae Hoon
Ewha Authors
문영철
SCOPUS Author ID
문영철scopus
Issue Date
2011
Journal Title
BLOOD
ISSN
0006-4971JCR Link
Citation
vol. 118, no. 21, pp. 896 - 897
Publisher
AMER SOC HEMATOLOGY
Indexed
SCI; SCIE; SCOPUS WOS
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE